Ojo 2003 reported that approximately 21.4% of hepatic transplant patients had antibodies for HCV, and that these patients had a relative risk of developing CKD of 1.15 95% CI 1.08 to 1.26 6.
Ojo 2003 reportó que un gran porcentaje de pacientes llevados a trasplante hepático tenía anticuerpos positivos para virus C, aproximadamente 21,4%.